BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 26, 2025
Home » Topics » Financings, BioWorld MedTech

Financings, BioWorld MedTech
Financings, BioWorld MedTech RSS Feed RSS

European Union flag, coins

European Commission providing $180M for public-private partnership investments in health care startups

Oct. 28, 2020
By Bernard Banga
PARIS – At the recent annual HealthTech Innovations Days in Paris, the European investment Fund (EIF) and the world’s largest life sciences consortium, EIT Health Germany, reported the development of a Venture Centre of Excellence (VCoE) in Europe.
Read More

Financings for Oct. 28, 2020

Oct. 28, 2020
Med-tech firms raising money in public or private financings, including: Biodesix , K?lahealth, Sidekick Health.
Read More

Financings for Oct. 27, 2020

Oct. 27, 2020
Med-tech firms raising money in public or private financings, including: Abm Respiratory Care, Caris Life Sciences, Eucrates Biomedical, Helius Medical Technologies, Intuitive Surgical.
Read More

Financings for Oct. 26, 2020

Oct. 26, 2020
Med-tech firms raising money in public or private financings, including: Goodcell, Lux Health Tech.
Read More
Device image

EU takes stake in Carthera to boost development of ultrasound-based technology for treating brain cancer

Oct. 26, 2020
By Bernard Banga
PARIS – Carthera SAS, of Paris, has obtained a $2.4 million grant and $12.5 million equity investment from the European Innovation Council (EIC) for the development of its ultrasound-based medical device for treating glioblastoma.
Read More

Financings for Oct. 23, 2020

Oct. 23, 2020
Med-tech firms raising money in public or private financings, including: Eucrates Biomedical Acquisition, Vapotherm, Xtant Medical Holdings.
Read More
10-22-Lenire-Device-hero

Neuromod scoops up €10.5M in series B funding

Oct. 22, 2020
By Meg Bryant
Neuromod Devices Ltd., which is developing an at-home, self-managed treatment for tinnitus, closed a €10.5 million (US$12.4 million) series B financing led by majority investor Fountain Healthcare Partners. The funds are earmarked for expanding European commercialization of the Lenire tinnitus treatment device, to scale up manufacturing, progress U.S. FDA regulatory approval and pursue opportunities with the U.S. Department of Veterans Affairs (VA).
Read More

Financings for Oct. 22, 2020

Oct. 22, 2020
Med-tech firms raising money in public or private financings, including: Cricket Health, Enviral Tech, Helius Medical Technologies, Invivo Therapeutics Holdings, Neodynamics.
Read More

Financings for Oct. 21, 2020

Oct. 21, 2020
Med-tech firms raising money in public or private financings, including: Astrotech, Eargo, Loyal, Phreesia.
Read More

Financings for Oct. 20, 2020

Oct. 20, 2020
Med-tech firms raising money in public or private financings, including: Cloudmd Software & Services, Diality, Medlite ID, Neuromod Devices, Stagezero Life Sciences.
Read More
Previous 1 2 … 201 202 203 204 205 206 207 208 209 … 252 253 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing